Hypomethylation of smoking-related genes is associated with future lung cancer in four prospective cohorts

[1]  M. Porta.  Faculty Opinions recommendation of Hypomethylation of smoking-related genes is associated with future lung cancer in four prospective cohorts. , 2016 .

[2]  Paolo Vineis,et al.  Dynamics of smoking-induced genome-wide methylation changes with time since smoking cessation. , 2015, Human molecular genetics.

[3]  M. Okano,et al.  Cohort Study , 2020, Definitions.

[4]  H. Brenner,et al.  F2RL3 methylation in blood DNA is a strong predictor of mortality. , 2014, International journal of epidemiology.

[5]  Å. Johansson,et al.  Smoke-related DNA methylation changes in the etiology of human disease. , 2014, Human molecular genetics.

[6]  K. Hansen,et al.  Functional normalization of 450k methylation array data improves replication in large cancer studies , 2014, Genome Biology.

[7]  K. Straif,et al.  Effect modification of the association of cumulative exposure and cancer risk by intensity of exposure and time since exposure cessation: a flexible method applied to cigarette smoking and lung cancer in the SYNERGY Study. , 2014, American journal of epidemiology.

[8]  Barbara Burwinkel,et al.  F2RL3 Methylation as a Biomarker of Current and Lifetime Smoking Exposures , 2013, Environmental health perspectives.

[9]  K. Tan,et al.  The effect of smoking on DNA methylation of peripheral blood mononuclear cells from African American women , 2014, BMC Genomics.

[10]  W. McArdle,et al.  Differences in smoking associated DNA methylation patterns in South Asians and Europeans , 2014, Clinical Epigenetics.

[11]  Haroon Naeem,et al.  Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array , 2014, BMC Genomics.

[12]  S. Beach,et al.  Changes in DNA methylation at the aryl hydrocarbon receptor repressor may be a new biomarker for smoking , 2013, Clinical Epigenetics.

[13]  Christian Gieger,et al.  Tobacco Smoking Leads to Extensive Genome-Wide Changes in DNA Methylation , 2013, PloS one.

[14]  Daniel J. Park,et al.  The use of DNA from archival dried blood spots with the Infinium HumanMethylation450 array , 2013, BMC Biotechnology.

[15]  Paolo Vineis,et al.  Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. , 2013, Human molecular genetics.

[16]  R. Vermeulen,et al.  Dynamic aspects of exposure history-do they matter? , 2012, Epidemiology.

[17]  Robert A Philibert,et al.  Demethylation of the aryl hydrocarbon receptor repressor as a biomarker for nascent smokers , 2012, Epigenetics.

[18]  M. J. Peck,et al.  Genomic impact of cigarette smoke, with application to three smoking-related diseases , 2012, Critical reviews in toxicology.

[19]  Weiliang Qiu,et al.  Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. , 2012, Human molecular genetics.

[20]  A. Oshlack,et al.  SWAN: Subset-quantile Within Array Normalization for Illumina Infinium HumanMethylation450 BeadChips , 2012, Genome Biology.

[21]  Devin C. Koestler,et al.  DNA methylation arrays as surrogate measures of cell mixture distribution , 2012, BMC Bioinformatics.

[22]  Robert A Philibert,et al.  Coordinated changes in AHRR methylation in lymphoblasts and pulmonary macrophages from smokers , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[23]  G. Davey Smith,et al.  Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. , 2012, International journal of epidemiology.

[24]  Bianca L. De Stavola,et al.  Gformula: Estimating Causal Effects in the Presence of Time-Varying Confounding or Mediation using the G-Computation Formula , 2011 .

[25]  Stijn Vansteelandt,et al.  Odds ratios for mediation analysis for a dichotomous outcome. , 2010, American journal of epidemiology.

[26]  Xiao Zhang,et al.  Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis , 2010, BMC Bioinformatics.

[27]  Paolo Vineis,et al.  Models of carcinogenesis: an overview. , 2010, Carcinogenesis.

[28]  Paolo Vineis,et al.  Third version: response to reviewers , 2010 .

[29]  I. Ial,et al.  Nature Communications , 2010, Nature Cell Biology.

[30]  N. Wormald,et al.  Models of the , 2010 .

[31]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[32]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[33]  D. Postma,et al.  Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers , 2005, European Respiratory Journal.

[34]  J Smith,et al.  Tobacco and cancer: recent epidemiological evidence. , 2004, Journal of the National Cancer Institute.

[35]  Office on Smoking.  The Health Consequences of Smoking , 2004 .

[36]  L. Weinehall,et al.  Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort- evaluation of risk factors and their interactions , 2003, Scandinavian journal of public health. Supplement.

[37]  Majid Ezzati,et al.  Estimates of global mortality attributable to smoking in 2000 , 2003, The Lancet.

[38]  J. Cerhan,et al.  Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  N. Chavannes,et al.  Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. , 2002, American journal of respiratory and critical care medicine.

[40]  D. English,et al.  The Melbourne Collaborative Cohort Study. , 2002, IARC scientific publications.

[41]  H. Boeing,et al.  EPIC-Germany – A Source for Studies into Diet and Risk of Chronic Diseases , 1999, Annals of Nutrition and Metabolism.

[42]  Elio Riboli,et al.  The EPIC Project: Rationale and study design , 1997 .

[43]  E Riboli,et al.  The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. , 1997, International journal of epidemiology.

[44]  O. Hankinson.  The aryl hydrocarbon receptor complex. , 1995, Annual review of pharmacology and toxicology.

[45]  B Rosner,et al.  Smoking cessation and decreased risk of stroke in women. , 1993, JAMA.

[46]  P. Newcomb,et al.  The health consequences of smoking. Cancer. , 1992, The Medical clinics of North America.

[47]  J. Robins,et al.  Identifiability and Exchangeability for Direct and Indirect Effects , 1992, Epidemiology.

[48]  J. Robins.  A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect , 1986 .

[49]  J. Loewen,et al.  The health consequences of smoking. , 1970, The Journal of the Arkansas Medical Society.